Naftifine hydrochloride gel 2%: An effective topical treatment for moccasin-type tinea pedis

Naftifine hydrochloride gel 2% is effect

Naftifine hydrochloride gel 2% is effective as a topical therapy for moccasin-type tinea pedis

📂 Article 📅 2013 🏛 Elsevier BV 🌐 English ⚖ 45 KB

Naftifine hydrochloride gel 2% is effect

Naftifine hydrochloride gel 2% is effective as a topical therapy for moccasin-type tinea pedis

📂 Article 📅 2013 🏛 Elsevier BV 🌐 English ⚖ 45 KB

Topical treatment for moccasin-type tine

Topical treatment for moccasin-type tinea pedis

✍ Greer, Donald L. 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 724 KB

Naftifine hydrochloride gel 2% is effica

Naftifine hydrochloride gel 2% is efficacious and safe for the treatment of tinea pedis: Results from a randomized, multicenter, double-blind, vehicle-controlled study

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

The cumulative effect of urea 40% combin

The cumulative effect of urea 40% combined with essential fatty acids in a bioadhesive delivery system and ketoconazole cream 2% for the treatment of moccasin tinea pedis in diabetics

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Trends in sun exposure knowledge, attitu

Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996",June K. Robinson; Darrell S. Rigel; Rex A. Amonette 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80119-3,CME examination," 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80118-1,Antimicrobial agents for the dermatologist. I. β-Lactam antibiotics and related compounds,Marcia E. Epstein; Maria Amodio-Groton; Neil S. Sadick 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80140-5,Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis,P. Kullavanijaya; S. Reangchainam; R. Ungpakorn 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80143-0,Effect of topical pramoxine on experimentally induced pruritus in humans,Gil Yosipovitch; Howard I. Maibach 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80149-1,Treatment of psoriasis with the pulsed dye laser,S.W. Lanigan; G.A. Katugampola 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80147-8,Response rates in photopheresis therapy for cutaneous T-cell lymphoma,Herschel S. Zackheim; Mohammed Kashani-Sabet 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80136-3,Keratosis lichenoides chronica: Response to topical calcipotriol,Marcelo H. Grunwald; Dafna Hallel-Halevy; Boaz Amichai 01909622,37,1997,1,10.1016/s0190-9622(97)70209-3,Relation between expression of adhesion molecules and clinical behavior in cutaneous follicle center cell lymphomas,Rob C. Beljaards; Peter Van Beek; Rein Willemze 01909622,37,1997,1,10.1016/s0190-9622(97)70208-1,A novel nonepidermolytic palmoplantar keratoderma: A clinical and histopathologic study of six cases,Cynthia M. Magro; Lynn A. Baden; Arthur N. Crowson; Paul E. Bowden; Howard P. Baden 01909622,37,1997,1,10.1016/s0190-9622(97)70216-0,"Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

✍ Gerald D. Weinstein; Gerald G. Krueger; Nicholas J. Lowe; Madeleine Duvic; David 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 765 KB